Neoplasia
Coordinator:Jill Pelling, Ph.D.
Supplemental Image
Database
Learning Objectives
Keywords
Clinical Topics
Conference
SUPPLEMENTAL IMAGE DATABASE
Benign vs. Malignant Neoplasms
Classification of Neoplasms
Benign tumors
Schwannoma
Leiomyoma of uterus
Meningioma
Adenomatous polyp of colon, gross
Adenomatous polyp of colon, micro
Teratoma
Fibroma of maxilla
Malignant tumors
Squamous cell carcinoma, gross
Squamous cell carcinoma, micro
Ca epidermoide
de células pequeñas y medianas, No queratinizante, No anaplásico, de tipo Transcisional
Adenocarcinoma
Ca de Mama
Macro. Gran tumor.
Ca de Mama Macro
con invasion cutanea y necrosis
Ca lobular de Mama micro
con células en fila india
Ca de Pene Macro
Teratocarcinoma
Melanoma, gross
Burkitt Lymphoma
Acute Myelogenous Leukemia, peripheral blood
Histologic diagnosis of malignancy
Benign tumors - growth by expansion
Resemble parent tissues, histologically and cytologically
Adenomatous polyp of colon, gross
Adenomatous polyp of colon, micro
Rabdomioma
Lipoma, gross
Lipoma, micro
Malignant tumors- growth by invasion
May resemble tissue of origin
Presence of anaplasia or cellular atypia
Mitotic activity, micro
Mitotic activity, micro
actividad mitótica micro
Invasion
Ca Broncogénico Macro
Metastases
Leiomyosarcoma, uterus, gross
Fibrosarcoma de partes blandas
Lung metastases, gross
Liver metastates, gross
Electron Microscopy
Tumor cytology
Tumor markers
Cytokeratin stain
Invasion and Metastases
Patterns of Spread
Direct extension
Metastatic spread
Hematogenous metastases
Lymphatic metastases
Biology of Invasion and Metastasis
Tumor heterogeneity
Invasion
Binding to ECM
Degradation of ECM
Movement through interstitial tissues
Metastasis
Invasion of the circulation
Escape from the circulation
Local growth
angiogenesis
Target organs in metastatic disease
Grading and staging of tumors
Cancer grading
Example: Grading of adenocarcinoma of the uterus
Grade 1
Grade 2
Grade 3
Cancer staging
T= size of primary tumor
N = number and distribution of node metastases
M= presence and extent of distant metastases
The growth of cancers
cell cycle kinetics
doubling time
growth factors
The causes of cancer
Chemical carcinogenesis
Initiation and promotion, multi-stage carcinogenesis
Classes of chemical carcinogens
Polycyclic aromatic hydrocarbons (PAH)
Aflatoxin
Aromatic amines
Nitrosamines
Metals
Factors influencing chemical carcinogenesis
Metabolism
Sex and hormonal status
Diet
Physical carcinogenesis
Ultraviolet Radiation
Gamma radiation
Asbestos
Foreign body
Viral carcinogenesis
DNA viruses
Papilloma viruses
Epstein Barr virus
Hepatitis B virus
Polyoma viruses (JC, BK)
RNA viruses
Human T-cell leukemia viruses I and II (HTLV-I and II)
Role of Oncogenes in Cancer
Identification of oncogenes
Mechanisms of activation of oncogenes
Point mutation - Ki-ras in pancreatic cancer
gene amplification - HER-2/neu, erb-B in breast and ovarian cancer
homogenously staining regions (HSRs), double minutes
translocation - Philadelphia chromosome in chronic myelogenous leukemia (CML)
t(8,14) in Burkitt lymphoma
function of oncogene products
G proteins
Growth factors
Membrane receptors/tyrosine kinases
Nuclear regulatory proteins
Role of tumor suppressor genes in cancer
Retinoblastoma (Rb gene)
Retinoblastoma (Rb) gene, patient photograph
Retinoblastoma, histology
The p53 gene
Hereditary cancer
BrCa I in breast/ovarian cancer
Immunology of cancer
Immunologic defenses against cancer in animals
Tumor antigens
Mechanisms of immunologic cytotoxicity
T cell-mediated cytotoxicity
Natural killer cell-mediated cytotoxicity
Macrophage-mediated cytotoxicity
Complement-mediated cytotoxicity
Immunologic defenses against cancer in humans
Systemic effects of cancer on the host
Paraneoplastic syndromes
Fever
Anorexia and weight loss
Endocrine syndromes
neurologic syndromes
skeletal muscle
hematologic syndromes
hypercoagulable state
gastrointestinal syndromes
renal syndromes
cutaneous syndromes
amyloidosis
Epidemiology of cancer
Incidence of cancer in the U.S.
Changing patterns of cancer incidence
Geographic and ethnic differences in cancer incidence